In May 2025, a video spread on social media that appeared to show Pope Leo XIV, born Robert Prevost, criticizing U.S. Vice ...

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

Tumors of CNS are common in adolescents and young adults (AYAs). As the second leading cause of cancer-related death, CNS tumors in AYAs require improved clinical management. In this review, we ...

HOUSTON - CNS Pharmaceuticals, Inc. (NASDAQ:CNSP), a micro-cap biopharmaceutical company with a market capitalization of $3.56 million, has announced the successful acquisition of Orphan Drug ...

The biotechs have been working together in the CNS space since a $1.7 billion biobucks pact in 2019, with their relationship strengthened in 2023 to focus on Voyager’s gene therapy program for ...

CNS cancer is a type of cancer that forms in the central nervous system. It includes brain stem glioma, craniopharyngioma, medulloblastoma and meningioma. Despite being an important driver of a ...

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments ...

Dyno-ahq is optimized for widespread and efficient delivery to the brain and throughout the CNS upon IV injection. With enhanced CNS delivery efficiencies compared to prior Dyno capsids ...

The dispute started when City of Norwich School (CNS) built the courts during Covid after it secured funding from the Lawn Tennis Association. Positioned just metres from homes on Lowther Road, the ...

The joint CRO’s main focus will be in CNS, although it will also offer services in cardiometabolic, renal and rare diseases. The merger marks a major step forward in deepening the CRO’s ...